You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Regimens

21 Items
Intent: Palliative
Funding:
ODB - General Benefit
    capecitabine
Jan 2024
Intent: Palliative
Apr 2023
Intent: Palliative
Nov 2019
Cancer Type:
Central Nervous System, 
Gastrointestinal, 
Colorectal, 
Esophagus, 
Gastric / Stomach, 
Hepatobiliary / Liver / Bile Duct, 
Pancreas, 
Genitourinary, 
Bladder / Urothelial, 
Prostate, 
Head and Neck, 
Lung, 
Small Cell, 
Unknown Primary
Intent: Palliative
Dec 2023
Intent: Palliative
Funding:
ODB - General Benefit
    etoposide - oral capsules
May 2019
Intent: Palliative
Aug 2020
Cancer Type:
Breast, 
Genitourinary, 
Renal cell / Kidney, 
Lung, 
Mesothelioma (Pleural), 
Non-Small Cell, 
Small Cell, 
Unknown Primary
Intent: Palliative
Jul 2018
Intent: Palliative
Oct 2023

Pages